Market Cap: $440.98M
RI
REGENXBIO Inc.
RGNX
NASDAQ (NASDAQ Global Select)USD
Market Cap: $440.98M
Analysts estimated RGNX earnings of $0.06 per share this quarter (Q2). RGNX's actual earnings were $0.43 per share.
RGNX EPS surprise of 626.35%Analysts estimated RGNX earnings of $-1.37 per share this quarter (Q1). RGNX's actual earnings were $-1.72 per share.
RGNX EPS surprise of -25.94%Analysts estimated RGNX earnings of $-0.98 per share this quarter (Q4). RGNX's actual earnings were $-1.30 per share.
RGNX EPS surprise of -33.31%Analysts estimated RGNX earnings of $-1.33 per share this quarter (Q3). RGNX's actual earnings were $-1.20 per share.
RGNX EPS surprise of 9.88%Analysts estimated RGNX earnings of $-1.12 per share this quarter (Q2). RGNX's actual earnings were $-1.38 per share.
RGNX EPS surprise of -22.99%Analysts estimated RGNX earnings of $0.49 per share this quarter (Q1). RGNX's actual earnings were $0.12 per share.
RGNX EPS surprise of 310.33%Analysts estimated RGNX earnings of $-1.17 per share this quarter (Q4). RGNX's actual earnings were $-1.01 per share.
RGNX EPS surprise of 13.65%Analysts estimated RGNX earnings of $-1.32 per share this quarter (Q2). RGNX's actual earnings were $-1.05 per share.
RGNX EPS surprise of 20.28%Analysts estimated RGNX earnings of $-1.28 per share this quarter (Q1). RGNX's actual earnings were $-1.38 per share.
RGNX EPS surprise of 7.46%Analysts estimated RGNX earnings of $-1.30 per share this quarter (Q4). RGNX's actual earnings were $-1.43 per share.
RGNX EPS surprise of 10.34%Analysts estimated RGNX earnings of $-1.55 per share this quarter (Q3). RGNX's actual earnings were $-1.41 per share.
RGNX EPS surprise of -8.92%